NASDAQ:QIPT Quipt Home Medical (QIPT) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free QIPT Stock Alerts $3.66 0.00 (0.00%) (As of 03:06 PM ET) Add Compare Share Share Today's Range$3.63▼$3.7250-Day Range$3.46▼$4.5152-Week Range$3.42▼$6.63Volume69,982 shsAverage Volume141,357 shsMarket Capitalization$155.81 millionP/E RatioN/ADividend YieldN/APrice Target$10.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Quipt Home Medical alerts: Email Address Quipt Home Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside173.2% Upside$10.00 Price TargetShort InterestBearish1.42% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth225.00%From $0.04 to $0.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.21 out of 5 starsMedical Sector518th out of 908 stocksSurgical & Medical Instruments Industry59th out of 97 stocks 3.3 Analyst's Opinion Consensus RatingQuipt Home Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageQuipt Home Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.42% of the float of Quipt Home Medical has been sold short.Short Interest Ratio / Days to CoverQuipt Home Medical has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Quipt Home Medical has recently increased by 0.83%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldQuipt Home Medical does not currently pay a dividend.Dividend GrowthQuipt Home Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for QIPT. Previous Next 1.9 News and Social Media Coverage News SentimentQuipt Home Medical has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Quipt Home Medical this week, compared to 0 articles on an average week.MarketBeat FollowsOnly 3 people have added Quipt Home Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Quipt Home Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.20% of the stock of Quipt Home Medical is held by insiders.Percentage Held by Institutions42.85% of the stock of Quipt Home Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Quipt Home Medical are expected to grow by 225.00% in the coming year, from $0.04 to $0.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quipt Home Medical is -40.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Quipt Home Medical is -40.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuipt Home Medical has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Quipt Home Medical Stock (NASDAQ:QIPT)Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.Read More QIPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QIPT Stock News HeadlinesApril 21, 2024 | theglobeandmail.comQuipt Home Medical: Top 10 Undervalued Micro Cap Stocks on TSX (QIPT)March 28, 2024 | finanznachrichten.deQuipt Home Medical Corp.: Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of ShareholdersApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 28, 2024 | ca.finance.yahoo.comStocks in play: Quipt Home Medical CorpMarch 28, 2024 | globenewswire.comQuipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of ShareholdersMarch 16, 2024 | finance.yahoo.comQIPT Apr 2024 10.000 callMarch 12, 2024 | globenewswire.comQuipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024February 24, 2024 | benzinga.comQuipt Home Medical Stock (NASDAQ:QIPT), Short Interest ReportApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 16, 2024 | realmoney.thestreet.comQuipt Home Medical just downgraded at Raymond James, here's whyFebruary 14, 2024 | seekingalpha.comQuipt Home Medical GAAP EPS of -$0.01 beats by $0.01, revenue of $65.4M beats by $1.1MFebruary 14, 2024 | globenewswire.comQuipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%February 7, 2024 | finance.yahoo.comQuipt Home Medical Corp. (QIPT) Expected to Beat Earnings Estimates: Should You Buy?February 1, 2024 | finance.yahoo.comQuipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024December 22, 2023 | finance.yahoo.comWall Street Analysts See a 100% Upside in Quipt Home Medical Corp. (QIPT): Can the Stock Really Move This High?December 15, 2023 | baystreet.caCanadian CPI Due Next WeekSeptember 1, 2023 | finance.yahoo.comQuipt Home Medical (TSE:QIPT) Is Doing The Right Things To Multiply Its Share PriceAugust 14, 2023 | finance.yahoo.comQuipt Home Medical Reports Strong Operational Performance With Record Third Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 64% and Adjusted EBITDA Growth of 80%August 1, 2023 | finance.yahoo.comQuipt Home Medical Corp. (TSE:QIPT) most popular amongst retail investors who own 60% of the shares, institutions hold 36%August 1, 2023 | finance.yahoo.comQuipt Home Medical Announces Date and Time for Fiscal Q3 2023 Conference Call and Audio WebcastJune 20, 2023 | finance.yahoo.comQuipt Home Medical Announces Up-listing to the Toronto Stock ExchangeJune 16, 2023 | finance.yahoo.comAn Intrinsic Calculation For Quipt Home Medical Corp. (CVE:QIPT) Suggests It's 21% UndervaluedJune 9, 2023 | msn.comLEEDE JONES GABLE Maintains Quipt Home Medical Corp (TSX:QIPT) Buy RecommendationMay 17, 2023 | markets.businessinsider.comQuipt Home Medical (QIPT) Receives a Buy from M PartnersMay 17, 2023 | markets.businessinsider.comQuipt Home Medical (QIPT) Receives a Buy from Benchmark Co.May 16, 2023 | finance.yahoo.comQuipt Home Medical Reports Record Second Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 73% and Adjusted EBITDA Growth of 86%May 9, 2023 | theglobeandmail.comClosing Bell: Quipt Home Medical Corp down on Monday (QIPT)See More Headlines Receive QIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/14/2024Today4/26/2024Next Earnings (Estimated)5/20/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:QIPT CUSIPN/A CIK1540013 Webwww.protechhomemedical.com Phone859-878-2220FaxN/AEmployees1,200Year FoundedN/APrice Target and Rating Average Stock Price Target$10.00 High Stock Price Target$10.00 Low Stock Price Target$10.00 Potential Upside/Downside+173.2%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E RatioN/A Forward P/E Ratio91.50 P/E GrowthN/ANet Income$-2,780,000.00 Net Margins-1.50% Pretax Margin-1.51% Return on Equity-3.57% Return on Assets-1.54% Debt Debt-to-Equity Ratio0.67 Current Ratio1.13 Quick Ratio0.79 Sales & Book Value Annual Sales$221.74 million Price / Sales0.70 Cash Flow$0.84 per share Price / Cash Flow4.34 Book Value$2.64 per share Price / Book1.39Miscellaneous Outstanding Shares42,570,000Free Float40,784,000Market Cap$155.81 million OptionableOptionable Beta0.60 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Gregory J. CrawfordChairman, President & CEOMr. Hardik MehtaChief Financial OfficerMr. David BachelderExecutive Vice President of OperationsMr. William Todd Zehnder (Age 49)Chief Strategy Officer & Investor Relations Comp: $308.24kCole StevensVP of Corporate Development & VP of Investor RelationsMr. Mark MilesVice President of Information TechnologyMr. Thomas W. Roehrig (Age 58)Executive Vice President of Finance Mr. Robert Grossman LLB (Age 50)Corporate Secretary More ExecutivesKey CompetitorsOrchestra BioMedNASDAQ:OBIOAlpha Tau MedicalNASDAQ:DRTSClearPoint NeuroNASDAQ:CLPTDelcath SystemsNASDAQ:DCTHProfound MedicalNASDAQ:PROFView All CompetitorsInstitutional OwnershipBridge City Capital LLCBought 7,244 shares on 4/12/2024Ownership: 0.112%Perritt Capital Management Inc.Sold 8,000 shares on 2/15/2024Ownership: 0.493%Tower Research Capital LLC TRC Bought 3,956 shares on 2/13/2024Ownership: 0.016%First Eagle Investment Management LLCBought 102,065 shares on 2/8/2024Ownership: 1.661%Fiera Capital CorpSold 52,000 shares on 2/8/2024Ownership: 0.487%View All Institutional Transactions QIPT Stock Analysis - Frequently Asked Questions Should I buy or sell Quipt Home Medical stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quipt Home Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" QIPT shares. View QIPT analyst ratings or view top-rated stocks. What is Quipt Home Medical's stock price target for 2024? 2 Wall Street analysts have issued twelve-month price objectives for Quipt Home Medical's stock. Their QIPT share price targets range from $10.00 to $10.00. On average, they predict the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 173.2% from the stock's current price. View analysts price targets for QIPT or view top-rated stocks among Wall Street analysts. How have QIPT shares performed in 2024? Quipt Home Medical's stock was trading at $5.09 at the beginning of the year. Since then, QIPT shares have decreased by 28.1% and is now trading at $3.66. View the best growth stocks for 2024 here. When is Quipt Home Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our QIPT earnings forecast. How were Quipt Home Medical's earnings last quarter? Quipt Home Medical Corp. (NASDAQ:QIPT) issued its earnings results on Wednesday, February, 14th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02. The firm had revenue of $65.36 million for the quarter, compared to analyst estimates of $63.43 million. Quipt Home Medical had a negative trailing twelve-month return on equity of 3.57% and a negative net margin of 1.50%. Who are Quipt Home Medical's major shareholders? Quipt Home Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bridge City Capital LLC (0.11%). How do I buy shares of Quipt Home Medical? Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:QIPT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quipt Home Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
